Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Myeloproliferative Disorders
×
30 days
×
Clear all
Filters
3
NCT04562389
2026-04-09
SENTRY
Karyopharm Therapeutics Inc
Phase 3
Active not recruiting
353 enrolled
NCT01366612
2026-04-03
FLUBUTBI
Hackensack Meridian Health
Phase 3
Terminated
53 enrolled
11 charts